Dabomb Protein Biotech (ROCO:6578) Accounts Payable: NT$19.5 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6578 Dabomb Protein Biotech Corp ROCO:6578
58 GF Score
Price NT$16.50
GF Value NT$16.60
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Dabomb Protein Biotech Accounts Payable?

Dabomb Protein Biotech ROCO:6578 +2.48% 58 Accounts Payable is NT$19.5 Mil as of Mar. 2026. GuruFocus rates ROCO:6578 with a GF Score™ of 58/100 and a GF Value™ of NT$16.60 (Fairly Valued). The stock has 1 warning sign investors should review.

Dabomb Protein Biotech's Accounts Payable for the quarter that ended in Mar. 2026 was NT$19.5 Mil.

Dabomb Protein Biotech's quarterly Accounts Payable declined from Sep. 2025 (NT$15.8 Mil) to Dec. 2025 (NT$12.6 Mil) but then increased from Dec. 2025 (NT$12.6 Mil) to Mar. 2026 (NT$19.5 Mil).

Dabomb Protein Biotech's annual Accounts Payable increased from Dec. 2023 (NT$8.7 Mil) to Dec. 2024 (NT$13.5 Mil) but then declined from Dec. 2024 (NT$13.5 Mil) to Dec. 2025 (NT$12.6 Mil).

Dabomb Protein Biotech Accounts Payable Related Terms

Dabomb Protein Biotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for Dabomb Protein Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech Accounts Payable Chart

Dabomb Protein Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.18 28.04 8.74 13.50 12.59

Dabomb Protein Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.19 14.34 15.81 12.59 19.52
ROCO:6578
58GF Score
Dabomb Protein Biotech Corp ROCO:6578
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dabomb Protein Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$19.5 Mil mean?
Dabomb Protein Biotech (ROCO:6578) has a Accounts Payable of NT$19.5 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Dabomb Protein Biotech and its competitors.
Is Dabomb Protein Biotech's Accounts Payable too high?
Dabomb Protein Biotech's current Accounts Payable is NT$19.5 Mil. Overall, Dabomb Protein Biotech has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's Accounts Payable compare to KHC and GIS?
Dabomb Protein Biotech's Accounts Payable of NT$19.5 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Consumer Packaged Goods company?
A good Accounts Payable depends on the Consumer Packaged Goods industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Dabomb Protein Biotech and its competitors. Dabomb Protein Biotech's current Accounts Payable is NT$19.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Fairly Valued. The stock's GF Value™ is NT$16.60, compared to a current price of NT$16.50 — trading 0.6% below its estimated fair value. The current Accounts Payable is NT$19.5 Mil. Dabomb Protein Biotech's overall GF Score™ is 58/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current Accounts Payable is NT$19.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?

Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be undervalued. The current stock price of NT$16.50 is trading 0.6% below its estimated GF Value™ of NT$16.60. GuruFocus considers Dabomb Protein Biotech to be Fairly Valued.

Key valuation signals for ROCO:6578:

  • Accounts Payable: NT$19.5 Mil
  • GF Value™: NT$16.60 vs. price of NT$16.50 (0.6% below fair value)
  • GF Score™: 58/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dabomb Protein Biotech Business Description

Address No. 52, Industrial 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
58GF Score

Get the complete analysis for ROCO:6578

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.50
Price
NT$16.60
GF Value